Tetra Bio-Pharma: Funding, Investors & Team (Sep 2026)
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program. Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.
Tetra Bio-Pharma has raised $6.0M across 1 funding round on record, the most recent a Post-IPO Debt of $6.0M announced in Aug 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tetra Bio-Pharma Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Tetra Bio-Pharma Funding Rounds
Tetra Bio-Pharma Founders and Leadership Team
Contact details for the Tetra Bio-Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Tetra Bio-Pharma Funding Compared to Other Biotechnology Startups
Tetra Bio-Pharma's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tetra Bio-Pharma in Biotechnology and Ottawa
Companies Similar to Tetra Bio-Pharma
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Tetra Bio-Pharma Funding FAQs
What does Tetra Bio-Pharma do?
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program. Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.
How much funding has Tetra Bio-Pharma raised?
Tetra Bio-Pharma has raised $6.0M across 1 round on record. The most recent is a Post-IPO Debt of $6.0M announced in Aug 2022.
When did Tetra Bio-Pharma last raise funding?
Tetra Bio-Pharma's most recent funding round on record is a Post-IPO Debt of $6.0M, announced in Aug 2022.
Who is the CEO of Tetra Bio-Pharma?
Guy Chamberland is listed as CEO at Tetra Bio-Pharma.
Where is Tetra Bio-Pharma headquartered?
Tetra Bio-Pharma is based in Ottawa, Ontario, Canada.
How many employees does Tetra Bio-Pharma have?
Tetra Bio-Pharma is in the 251-500 employee band.
How does Tetra Bio-Pharma's funding compare to other Biotechnology startups?
Tetra Bio-Pharma's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Tetra Bio-Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tetra Bio-Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.